Medicina Clinica e delle Patologie Emergenti
About Medicina Clinica e delle Patologie Emergenti
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Kowa Research Europe
3
Hoffmann-La Roche
2
Clinical Trials at Medicina Clinica e delle Patologie Emergenti
During the past decade, Medicina Clinica e delle Patologie Emergenti conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Compare the Efficacy of Pitavastatin With That of Atorvastatin in Lowering Cholesterol Levels
2005-10-01
2006-11-01
Completed
830
Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin
2005-09-01
2006-10-01
Completed
857
Long-Term Extension Study of Pitavastatin in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia
2006-07-01
2007-11-01
Completed
1,355
Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)
2018-06-06
2023-02-17
Terminated
1,054
A Study to Evaluate the Safety, Tolerability, and Efficacy of Long-Term Gantenerumab Administration in Participants With Alzheimer's Disease (AD)
2021-02-01
2023-03-06
Terminated
1,379
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Medicina Clinica e delle Patologie Emergenti
According to Clinical.Site data, the most researched conditions in "Medicina Clinica e delle Patologie Emergenti" are
"Dyslipidemia" (3 trials), "Alzheimer Disease" (2 trials), "Hypercholesterolemia" (2 trials) and "Primary Hypercholesterolemia" (1 trials). Many other conditions were trialed in "Medicina Clinica e delle Patologie Emergenti" in a lesser frequency.
Clinical Trials Intervention Types at Medicina Clinica e delle Patologie Emergenti
Most popular intervention types in "Medicina Clinica e delle Patologie Emergenti" are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "Pitavastatin" (3 trials), "Gantenerumab" (2 trials), "Atorvastatin" (1 trials), "Placebo" (1 trials) and "Simvastatin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Medicina Clinica e delle Patologie Emergenti
The vast majority of trials in "Medicina Clinica e delle Patologie Emergenti" are
5 trials for "All" genders.
Clinical Trials Status at Medicina Clinica e delle Patologie Emergenti
Currently, there are NaN active trials in "Medicina Clinica e delle Patologie Emergenti".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Medicina Clinica e delle Patologie Emergenti,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Medicina Clinica e delle Patologie Emergenti, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".